ATE408013T1 - Infektiöses cdna klon des gb-virus b und dessen verwendungen - Google Patents

Infektiöses cdna klon des gb-virus b und dessen verwendungen

Info

Publication number: ATE408013T1
Authority: AT; Austria
Prior art keywords: virus; hcv; infectious; cdna clone; clone
Prior art date: 1999-06-04

Application number

AT00939534T

Other languages

English (en)

Inventor

Jens Bukh

Masayuki Yanagi

Suzanne Emerson

Robert Purcell

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-04

Filing date

2000-06-02

Publication date

2008-09-15

2000-06-02 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2008-09-15 Application granted granted Critical

2008-09-15 Publication of ATE408013T1 publication Critical patent/ATE408013T1/de

Links

208000015181 infectious disease Diseases 0.000 title abstract 4
230000002458 infectious effect Effects 0.000 title abstract 4
241000700605 Viruses Species 0.000 title 1
241001529916 Hepatitis GB virus B Species 0.000 abstract 5
108091028043 Nucleic acid sequence Proteins 0.000 abstract 3
150000007523 nucleic acids Chemical group 0.000 abstract 3
VOWCXSYDBWCCCF-QIBOXNKSSA-N gbv-b Chemical compound C([C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C1=CC=C(O)C=C1 VOWCXSYDBWCCCF-QIBOXNKSSA-N 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT00939534T 1999-06-04 2000-06-02 Infektiöses cdna klon des gb-virus b und dessen verwendungen ATE408013T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13769499P	1999-06-04	1999-06-04

Publications (1)

Publication Number	Publication Date
ATE408013T1 true ATE408013T1 (de)	2008-09-15

Family

ID=22478653

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00939534T ATE408013T1 (de)	1999-06-04	2000-06-02	Infektiöses cdna klon des gb-virus b und dessen verwendungen

Country Status (5)

Country	Link
EP (1)	EP1185665B1 (de)
AT (1)	ATE408013T1 (de)
AU (1)	AU5460900A (de)
DE (1)	DE60040219D1 (de)
WO (1)	WO2000075337A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9912432D0 (en) *	1999-05-27	1999-07-28	Angeletti P Ist Richerche Bio	Novel gbv sequence
US7141405B2 (en) *	1999-06-04	2006-11-28	Board Of Regents, The University Of Texas System	Chimeric GB virus B (GBV-B)
US6870043B2 (en) *	2000-04-06	2005-03-22	The University Of Iowa Research Foundation	Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4 positive T cells
WO2003059944A2 (en) *	2002-01-15	2003-07-24	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa	Gb virus b based replicons and replicon enhanced cells
JP5250179B2 (ja)	2002-11-08	2013-07-31	ザアドミニストレイターズオブザテューレインエデュケイショナルファンド	フラビウイルス融合インヒビター
CA2539457C (en)	2003-09-19	2013-12-03	Tokyo Metropolitan Organization For Medical Research	Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
US7790448B2 (en)	2003-09-19	2010-09-07	Tokyo Metropolitan Organization For Medical Research	Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene
US7659103B2 (en)	2004-02-20	2010-02-09	Tokyo Metropolitan Organization For Medical Research	Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
WO2006036879A2 (en) *	2004-09-27	2006-04-06	Board Of Regents, The University Of Texas System	Chimeric gb virus b (gbv-b)
US9775894B2 (en)	2013-07-09	2017-10-03	University Of Washington Through Its Center For Commercialization	Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995021922A2 (en) *	1994-02-14	1995-08-17	Abbott Laboratories	Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use

2000
- 2000-06-02 WO PCT/US2000/015293 patent/WO2000075337A1/en not_active Ceased
- 2000-06-02 EP EP00939534A patent/EP1185665B1/de not_active Expired - Lifetime
- 2000-06-02 AT AT00939534T patent/ATE408013T1/de not_active IP Right Cessation
- 2000-06-02 AU AU54609/00A patent/AU5460900A/en not_active Abandoned
- 2000-06-02 DE DE60040219T patent/DE60040219D1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1185665B1 (de)	2008-09-10
WO2000075337A1 (en)	2000-12-14
AU5460900A (en)	2000-12-28
EP1185665A1 (de)	2002-03-13
DE60040219D1 (de)	2008-10-23

Similar Documents

Publication	Publication Date	Title
WO2006096459A3 (en)	2008-08-21	Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof
UA85536C2 (en)	2009-02-10	Viral antigens
PT1685243E (pt)	2008-09-24	Linhas celulares aviárias imortalizadas para a produção de vírus
ATE542826T1 (de)	2012-02-15	Inhibitoren des hepatitis-c-virus
DK1554301T3 (da)	2011-01-24	Dengue-vaccine med en fælles udeladelse af 30 nukleotider i Dengue-typerne 1's og 2's3'UTR
HRP20041085B1 (hr)	2014-01-31	Inhibitori hepatitis c virusa
AU2003284689A8 (en)	2004-12-13	Nucleic acid construct containing hepatitis c virus (hcv) of genocype 2a genome-origin nucleic acid and cell having the nucleic acid construct transferred thereinto
WO2006133911A3 (en)	2007-04-12	Hepatitis c virus nucleic acid vaccine
ES2062887T3 (es)	1994-12-16	Secuencias de adn derivadas del genoma del papilomavirus hpv39, su aplicacion al diagnostico in vitro y a la produccion de preparado inmunogeno.
ATE408013T1 (de)	2008-09-15	Infektiöses cdna klon des gb-virus b und dessen verwendungen
WO2006038908A3 (en)	2008-09-12	Ancestral and cot viral sequences, proteins and immunogenic compositions
TW200502246A (en)	2005-01-16	Vaccine
DK1425404T3 (da)	2008-10-06	Vaccinia-MVA-E3L-mutanter og anvendelse deraf
WO2001021807A8 (en)	2001-10-11	Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
ATE461283T1 (de)	2010-04-15	Neue vollständige genomische rna des japanenzephalitis-virus, infektiöse jev cdna daraus und deren verwendung
IL161901A0 (en)	2005-11-20	Nucleosides, preparation thereof and use as inhibiDevice for the reading and the signalling of environmental parameters tors of rna viral polymerases
DE60034884D1 (de)	2007-06-28	Klonierte genome von infektiösen hepatitis c viren genotyp 2a und deren verwendungen
WO2001060838A3 (en)	2002-01-24	Aids ancestral viruses and vaccines
MXPA02012593A (es)	2004-05-17	Particulas de tipo virus del virus de la diarrea viral bovina.
NO20005608D0 (no)	2000-11-07	Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
WO2005001029A3 (en)	2006-01-05	Ancestral viruses and vaccines
PT1383796E (pt)	2009-07-21	Estirpe neurovirulenta do vírus do nilo ocidental e as suas aplicações
DE60229966D1 (de)	2009-01-02	Diabetesmodell
WO2000075352A3 (en)	2001-11-15	Hcv/bvdv chimeric genomes and uses thereof
WO2006036879A3 (en)	2006-08-10	Chimeric gb virus b (gbv-b)

Legal Events

Date	Code	Title	Description
2009-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties